Headline News about Novartis Ag ADR
(NVS) - Analyzing Novartis's Short Interest
December 20, 2023
Via Benzinga
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Via Benzinga
Exposures
Product Safety
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Via Benzinga
How Is The Market Feeling About Novartis?
November 10, 2023
Via Benzinga
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Via Benzinga
Exposures
Product Safety
Via Benzinga
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript
October 24, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.